The Zhitong Finance App learned that on July 10, the China Securities Regulatory Commission announced the disclosure of supplementary materials for overseas issuance and filing (July 6, 2026 to July 10, 2026). The Securities Regulatory Commission requested Sino Healthcare to provide additional information on the specific implementation of overseas investment and foreign exchange registration procedures involving the company's establishment of overseas subsidiaries, and issue a concluding opinion on compliance. Whether the company's business is involved in advanced brain-computer interface technology and specific circumstances in actual operation. According to the Hong Kong Stock Exchange disclosure on May 27, Sano Healthcare (688108.SH) submitted a listing application to the main board of the Hong Kong Stock Exchange, and CMB International was its sole sponsor.

The Zhitong Finance App learned that on July 10, the China Securities Regulatory Commission announced the disclosure of supplementary materials for overseas issuance and filing (July 6, 2026 to July 10, 2026). The Securities Regulatory Commission requested Sino Healthcare to provide additional information on the specific implementation of overseas investment and foreign exchange registration procedures involving the company's establishment of overseas subsidiaries, and issue a concluding opinion on compliance. Whether the company's business is involved in advanced brain-computer interface technology and specific circumstances in actual operation. According to the Hong Kong Stock Exchange disclosure on May 27, Sano Healthcare (688108.SH) submitted a listing application to the main board of the Hong Kong Stock Exchange, and CMB International was its sole sponsor.